BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/16/2014 3:53:00 PM | Browse: 1425 | Download: 1862
 |
Received |
|
2014-02-19 10:49 |
 |
Peer-Review Started |
|
2014-02-20 14:50 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-03-23 15:46 |
 |
Revised |
|
2014-04-16 23:08 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-06-26 16:56 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-06-26 17:31 |
 |
Articles in Press |
|
2014-06-26 17:59 |
 |
Edit the Manuscript by Language Editor |
|
2014-07-27 21:33 |
 |
Typeset the Manuscript |
|
2014-09-25 11:20 |
 |
Publish the Manuscript Online |
|
2014-10-16 15:53 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qing-Hua Ke, Shi-Qiong Zhou, Ji-Yuan Yang, Wei Du, Gai Liang, Yong Lei and Fei Luo |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ji-Yuan Yang, Professor, Department of Chemoradiotherapy, Oncology Hospital of Jingzhou, No. 40 Jinglong Road, Shashi District, Jingzhou 434000, Hubei Province, China. yangjiyuancn@yeah.net |
| Key Words |
Chemoradiotherapy; Radiosensitizer; S-1; Pancreatic cancer; CA19-9 |
| Core Tip |
The article describes a study of the combination of S-1 with gemcitabine S-1 followed by oral S-1 with concurrent radiotherapy and maintenance therapy with S-1 for locally advanced pancreatic cancer. It is considered a well-tolerated, promising and effective treatment for unresectable advanced pancreatic cancer. |
| Publish Date |
2014-10-16 15:53 |
| Citation |
Ke QH, Zhou SQ, Yang JY, Du W, Liang G, Lei Y, Luo F. S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer. World J Gastroenterol 2014; 20(38): 13987-13992 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i38/13987.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i38.13987 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.